SkinHealth Systems Inc. SKIN
Regular-session close
After hours · Nov 13, 4:00 PM ET
- YTD
- +1,073.38%
- 1 year
- +1,154.62%
- Market cap
- 106.26M
- Revenue (ttm)
- 347.62M
- Profit margin
- -8.10%
- EPS (ttm)
- -2.98
- Shares out
- 124.12M
- Forward P/E
- -9.00
- YTD return
- +1073.38%
- 1-year return
- +1154.62%
- Volume
- 86.34K
- Avg volume
- 38.43K
- Open
- 15.75
- Previous close
- 15.96
- Day's range
- 15.27 – 16.64
- 52-week range
- 9.68 – 33.00
- Beta
- 0.91
- Analysts
- Hold
- Price target
- 1.72 (-89.5%)
5D +5.55 (+53.16%)
Key statistics
- Enterprise value
- 390.66M
- PEG ratio
- 0.00
- Price / sales
- 0.51
- Price / book
- 2.99
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -19.10%
- Free cash flow
- -375.50K
- Total cash
- 358.89M
- Total debt
- 568.33M
- Return on equity
- -37.64%
- Short % of float
- 16.11%
- 50-day average
- 1.58
- 200-day average
- 2.17
Fundamental scorecard
7 of 25 checks passed on SKIN’s reported financials
7of 25 checks passed
- Value 3 of 5
- Growth 2 of 5
- Profitability 1 of 5
- Financial health 1 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | -0.12 | -0.15 | -0.03 | -25.00% |
| Aug 8, 2024 | Jun 1, 2024 | -0.05 | -0.10 | -0.05 | -100.00% |
| Aug 8, 2024 | Jun 1, 2024 | -0.05 | — | — | — |
| May 9, 2024 | Mar 1, 2024 | -0.14 | -0.10 | +0.04 | +28.57% |
| May 9, 2024 | Mar 1, 2024 | -0.14 | — | — | — |
| Mar 12, 2024 | Dec 1, 2023 | -0.11 | -0.07 | +0.04 | +36.36% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 13, 2024 | Canaccord Genuity | main | Hold | Hold |
| Aug 12, 2024 | Canaccord Genuity | main | Hold | Hold |
| Aug 9, 2024 | Piper Sandler | reit | Underweight | Underweight |
| Jul 26, 2024 | Stifel | main | Hold | Hold |
| Jul 11, 2024 | Piper Sandler | main | Underweight | Underweight |
| May 13, 2024 | DA Davidson | main | Buy | Buy |
About SkinHealth Systems Inc.
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Country
- United States
- Website
- beautyhealth.com
News
TD Cowen Maintains Hold on SkinHealth Systems, Raises Price Target to $14
Investing in SkinHealth Systems Inc. (SKIN)? Don't Miss Assessing Its International Revenue Trends
Beauty Health Q3 2026 Earnings Call Transcript Beauty Health Narrows FY2026 Sales Guidance from $280.000M-$290.000M to $281.000M-$287.000M vs $285.018M Est
Beauty Health Q3 EPS $(0.14) Beats $(0.26) Estimate, Sales $69.200M Beat $67.943M Estimate
Your note
Sign in to keep a note on SKIN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BECK MARLA MALCOLM | Chief Executive Officer | Stock Award(Grant) | Apr 8, 2024 | 1,078,210 |
| CAPELLAS MICHAEL D | Director | Stock Award(Grant) | Jul 7, 2024 | 276,146 |
| FEW JULIUS | Director | Stock Award(Grant) | Jul 7, 2024 | 194,341 |
| GRUBER DESIREE | Director | Sale | Nov 19, 2024 | 119,514 |
| KERRICK MICHELLE C. | Director | Stock Award(Grant) | Jul 7, 2024 | 116,762 |
| MILLER BRIAN CHRISTOPHER | Director | Stock Award(Grant) | Jul 7, 2024 | 169,984 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 14.99% | 18,603,037 | 26.79M | Sep 29, 2024 |
| Janus Henderson Group PLC | 9.03% | 11,209,408 | 16.14M | Sep 29, 2024 |
| Blackrock Inc. | 4.53% | 5,620,752 | 8.09M | Sep 29, 2024 |
| Vanguard Group Inc | 4.46% | 5,536,433 | 7.97M | Sep 29, 2024 |
| Braidwell LP | 3.26% | 4,049,694 | 5.83M | Sep 29, 2024 |
| Jacobs Levy Equity Management, Inc. | 2.01% | 2,499,652 | 3.60M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Janus Henderson Contrarian Fund | 8.96% | 11,117,965 | 16.01M | Sep 29, 2024 |
| Fidelity Growth Company Fund | 3.10% | 3,848,924 | 5.54M | Oct 30, 2024 |
| Vanguard Total Stock Market Index Fund | 2.17% | 2,698,071 | 3.89M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.59% | 1,979,456 | 2.85M | Oct 30, 2024 |
| Fidelity Growth Company K6 Fund | 1.15% | 1,430,456 | 2.06M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.02% | 1,266,061 | 1.82M | Sep 29, 2024 |
